ClinicalTrials.govpublic full text
Safety Study of Anti-Programmed Death-Ligand 1 in Hematologic Malignancy
non-hodgkin's lymphoma, hodgkin lymphoma, multiple myeloma, chronic myelogenous leukemia, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 887437
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.